- Home
- SHLS vs BBOT Comparison
SHLS vs BBOT Comparison
Compare SHLS & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.11
N/A
Current Price
$12.60
Company Overview
Basic Information| Metric | SHLS | BBOT |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHLS | BBOT |
|---|---|---|
| Price | $8.11 | $12.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 5 |
| Target Price | $9.42 | ★ $23.80 |
| AVG Volume (30 Days) | ★ 4.1M | 165.5K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $433,993,000.00 | N/A |
| Revenue This Year | $20.62 | N/A |
| Revenue Next Year | $18.88 | N/A |
| P/E Ratio | $42.50 | ★ N/A |
| Revenue Growth | ★ 2.68 | N/A |
| 52 Week Low | $2.71 | $8.50 |
| 52 Week High | $11.36 | $14.87 |
Technical Indicators
Market Signals| Indicator | SHLS | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 46.35 | N/A |
| Support Level | $7.68 | N/A |
| Resistance Level | $8.39 | N/A |
| Average True Range (ATR) | 0.44 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 69.60 | 0.00 |
Price Performance
Historical Comparison SHLS
BBOT
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.